» Articles » PMID: 35432799

Ischemic Post-conditioning is Neuroprotective Even at Delayed TPA Administration After Embolic Stroke in Female Rats

Abstract

Objectives: Delayed tissue plasminogen activator (tPA) thrombolysis is accompanied by different complications in stroke patients. Studies reported sex differences in stroke therapy. Ischemic postconditioning (PC) unveils neuroprotection in stroke models. In this study, we investigate the combined effect of delayed tPA therapy and PC procedure during an embolic stroke experimental model in female rats.

Materials And Methods: Female Wistar rats were randomly divided into control (saline), tPA, PC, and tPA+PC groups after stroke induction via clot injection to the middle cerebral artery. tPA treatment was initiated 6 hr after stroke, and PC procedure was performed 6.5 hr post-ischemia induction (occlusion: 10 sec; reopening: 30 sec; 5 cycles). The cerebral blood flow (CBF) was recorded up to 60 min from IV tPA injection time. The parameters of brain edema, infarct volume, disruption of the blood-brain barrier (BBB), behavioral tests, and matrix metalloproteinases-9 (MMP-9) were evaluated.

Results: This study revealed that PC conduction prevents excessive CBF increase by tPA and played a protective role in infarct volume reduction (<0.05). The combination of PC and tPA reduced the infarct volume, brain edema, and protected BBB. tPA+PC could alleviate neurobehavioral disorders compared with control or tPA. Moreover, PC had the capability of MMP-9 reduction when combined with delayed tPA (<0.05).

Conclusion: Conduction of PC not only alleviated some stroke complications but also enhanced the therapeutic time window of tPA in female rats under embolic stroke.

Citing Articles

Neuroprotective effect of ischemic postconditioning against hyperperfusion and its mechanisms of neuroprotection.

Bagheri S, Allahtavakoli M, Hakimizadeh E J Res Med Sci. 2024; 29:31.

PMID: 39239075 PMC: 11376715. DOI: 10.4103/jrms.jrms_341_22.

References
1.
Yao G, Zhu Q, Xia J, Chen F, Huang M, Liu J . Ischemic postconditioning confers cerebroprotection by stabilizing VDACs after brain ischemia. Cell Death Dis. 2018; 9(10):1033. PMC: 6180002. DOI: 10.1038/s41419-018-1089-5. View

2.
Meirhaeghe A, Cottel D, Cousin B, Dumont M, Marecaux N, Amouyel P . Sex Differences in Stroke Attack, Incidence, and Mortality Rates in Northern France. J Stroke Cerebrovasc Dis. 2018; 27(5):1368-1374. DOI: 10.1016/j.jstrokecerebrovasdis.2017.12.023. View

3.
Emberson J, Lees K, Lyden P, Blackwell L, Albers G, Bluhmki E . Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014; 384(9958):1929-35. PMC: 4441266. DOI: 10.1016/S0140-6736(14)60584-5. View

4.
Hill M, Barber P, Takahashi J, Demchuk A, Feasby T, Buchan A . Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ. 2000; 162(9):1281-4. PMC: 1232409. View

5.
Liu R, Wen Y, Perez E, Wang X, Day A, Simpkins J . 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res. 2005; 1060(1-2):55-61. DOI: 10.1016/j.brainres.2005.08.048. View